Alzheimer's disease clinical trials
852 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all alzheimer's disease studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting alzheimer's disease studies. A study counts once in each state where it has a site.
- California77
- Florida68
- Massachusetts60
- New York58
- Texas52
- Missouri37
- Arizona33
- North Carolina32
- Pennsylvania32
- Georgia31
- New Jersey31
- Ohio31
Also in China (135), France (92), Canada (67), Italy (63), United Kingdom (41), Spain (40), South Korea (32), Taiwan (27).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 113
- Phase 143
- Phase 1 / Phase 223
- Phase 277
- Phase 2 / Phase 311
- Phase 341
- Phase 413
- No phase (devices, programs)369
- Observational262
Recently updated studies
Recruiting alzheimer's disease studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 1NCT07169630
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
Ages 50 Years – 100 Years · Bethesda, Maryland · National Institute of Mental Health (NIMH)
- RecruitingObservationalNCT07099053
Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
Ages 55 Years – 110 Years · Baltimore, Maryland · National Institute on Aging (NIA)
- RecruitingObservationalNCT06104852
Triage Survey for Neurology Research Eligibility
Ages 18 Years and over · Boston, Massachusetts · Watertown, Massachusetts +1 more · Adams Clinical
- RecruitingPhase 2NCT07721467
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Ages 65 Years – 120 Years · Baltimore, Maryland · National Institute on Aging (NIA)
- RecruitingPhase 3NCT06585787
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Ages 55 Years – 90 Years · Chandler, Arizona · Gilbert, Arizona +220 more · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- RecruitingPhase 1NCT07853781
First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE4D Imaging in Healthy Volunteers
Ages 18 Years – 105 Years · Bethesda, Maryland · National Institute of Mental Health (NIMH)
- RecruitingNo phase (devices, programs)NCT04855630
Combating Alzheimer's Through Sleep and Exercise
Ages 55 Years – 80 Years · Miami, Florida · University of Miami
- RecruitingPhase 3NCT06976216
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Ages 60 Years – 85 Years · Long Beach, California · Redlands, California +101 more · Bristol-Myers Squibb
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.